Literature DB >> 16443792

Defective induction of CTLA-4 in the NOD mouse is controlled by the NOD allele of Idd3/IL-2 and a novel locus (Ctex) telomeric on chromosome 1.

Marie Lundholm1, Vinicius Motta, Anna Löfgren-Burström, Nadia Duarte, Marie-Louise Bergman, Sofia Mayans, Dan Holmberg.   

Abstract

Cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), or CD152, is a negative regulator of T-cell activation and has been shown to be associated with autoimmune diseases. Previous work has demonstrated a defect in the expression of this molecule in nonobese diabetic (NOD) mice upon anti-CD3 stimulation in vitro. Using a genetic approach we here demonstrate that a novel locus (Ctex) telomeric on chromosome 1 together with the Idd3 (Il-2) gene confers optimal CTLA-4 expression upon CD3 activation of T-cells. Based on these data, we provide a model for how gene interaction between Idd3 (IL-2), Ctex, and Idd5.1 (Ctla-4) could confer susceptibility to autoimmune diabetes in the NOD mouse. Additionally, we showed that the Ctex and the Idd3 regions do not influence inducible T-cell costimulator (ICOS) protein expression in NOD mice. Instead, as previously shown, higher ICOS levels in NOD mice appear to be controlled by gene(s) in the Idd5.1 region, possibly a polymorphism in the Icos gene itself.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443792     DOI: 10.2337/diabetes.55.02.06.db05-1240

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Modeling CTLA4-linked autoimmunity with RNA interference in mice.

Authors:  Zhibin Chen; John Stockton; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

2.  A cluster of coregulated genes determines TGF-beta-induced regulatory T-cell (Treg) dysfunction in NOD mice.

Authors:  Anna Morena D'Alise; Ayla Ergun; Jonathan A Hill; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-04       Impact factor: 11.205

3.  Altered connexin 43 expression underlies age-dependent decrease of regulatory T cell suppressor function in nonobese diabetic mice.

Authors:  Michal Kuczma; Cong-Yi Wang; Leszek Ignatowicz; Robert Gourdie; Piotr Kraj
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

4.  Increased expression of TACI on NOD B cells results in germinal centre reaction anomalies, enhanced plasma cell differentiation and immunoglobulin production.

Authors:  Viqar S Banday; Radha Thyagarajan; Mia Sundström; Kristina Lejon
Journal:  Immunology       Date:  2016-08-23       Impact factor: 7.397

Review 5.  Immune tolerance induction by integrating innate and adaptive immune regulators.

Authors:  Jun Suzuki; Camillo Ricordi; Zhibin Chen
Journal:  Cell Transplant       Date:  2009-11-16       Impact factor: 4.064

6.  A type 1 diabetes subgroup with a female bias is characterised by failure in tolerance to thyroid peroxidase at an early age and a strong association with the cytotoxic T-lymphocyte-associated antigen-4 gene.

Authors:  J M M Howson; D B Dunger; S Nutland; H Stevens; L S Wicker; J A Todd
Journal:  Diabetologia       Date:  2007-02-14       Impact factor: 10.122

7.  Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms.

Authors:  Peng Gao; Yan Jiao; Qing Xiong; Cong-Yi Wang; Ivan Gerling; Weikuan Gu
Journal:  Curr Genomics       Date:  2008       Impact factor: 2.236

8.  Association of CD247 (CD3ζ) gene polymorphisms with T1D and AITD in the population of northern Sweden.

Authors:  Dan Holmberg; Karin Ruikka; Petter Lindgren; Mats Eliasson; Sofia Mayans
Journal:  BMC Med Genet       Date:  2016-10-04       Impact factor: 2.103

9.  The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future.

Authors:  Yi-Guang Chen; Clayton E Mathews; John P Driver
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-23       Impact factor: 5.555

Review 10.  Altered immune regulation in type 1 diabetes.

Authors:  András Zóka; Györgyi Műzes; Anikó Somogyi; Tímea Varga; Barbara Szémán; Zahra Al-Aissa; Orsolya Hadarits; Gábor Firneisz
Journal:  Clin Dev Immunol       Date:  2013-08-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.